Filing Details
- Accession Number:
- 0000950170-25-042060
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-19 16:32:22
- Reporting Period:
- 2025-03-17
- Filing Date:
- 2025-03-19
- Accepted Time:
- 2025-03-19 16:32:22
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
949858 | Achieve Life Sciences Inc. | ACHV | In Vitro & In Vivo Diagnostic Substances (2835) | 954343413 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1713369 | Alistair Richard Stewart | 22722 29Th Dr Se Suite 100 Bothell WA 98021 | Chieve Executive Officer | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-03-17 | 10,000 | $2.86 | 60,876 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 359 | Indirect | By Spouse |
Common Stock | 882 | Indirect | By Ricanto Limited |
Footnotes
- In January 2025, pursuant to an agreement between the Reporting Person and the Issuer, the Reporting Person relinquished the stock option to purchase 67,500 shares of the Issuer's common stock granted on January 13, 2025.
- The reporting holder is a principal owner of Ricanto Limited.